Global BNP and NT-proBNP Market Size, Share & Industry Trends Analysis Report By Location of Testing, By Application (Myocardial Infarction, Acute Coronary Syndrome (ACS), Congestive Heart Failure (CHF)), By Regional Outlook and Forecast, 2022 - 2028

The Global BNP and NT-proBNP Market size is expected to reach $2.2 billion by 2028, rising at a market growth of 11.4% CAGR during the forecast period.

BNP (B-type natriuretic peptide) & NT-proBNP (N-terminal pro B-type natriuretic peptide) are two extensively used biomarkers that are used to diagnose heart failure and lower ejection fraction, evaluate the effectiveness of therapy, and predict outcomes. As cardiomyocytes stretch, they release proBNP, which breaks down into two circulating fragments. The first fragment is the 32-amino acid C-terminal BNP, and the second fragment is inactive 76-amino acid NT-proBNP.

Both pieces are frequently utilized to aid in detecting heart failure, make predictions about results, and monitor the impact of treatment. The heart produces peptides known as natriuretic peptides. N-terminal pro-B-type natriuretic peptide and Brain natriuretic peptide (BNP) are the two primary forms of these chemicals. BNP & NT-proBNP are typically only detected in trace amounts in the blood.

However, high levels may indicate that the heart isn't supplying the body with enough blood as it requires. Heart failure, sometimes called congestive heart failure, occurs when this happens. Natriuretic peptide assays gauge the blood's levels of NT-proBNP or BNP. Although they employ various parameters, they are both helpful in diagnosing heart failure. The option users will rely on the tools the suggested laboratory of the provider has.

The main biological distinction between BNP & NT-proBNP is that BNP acts as a hormone and is biologically active. In contrast, NT-proBNP is passively excreted from the body as well as is not biologically active. Thus, NT-proBNP tends to have a longer half-life than BNP, which has a significantly shorter half-life. As a result, NT-proBNP circulates in the bloodstream at higher quantities, which suggests that it is more likely to be sensitive for identifying earlier stages of heart failure since it does so at somewhat elevated levels.

COVID-19 Impact Analysis

The COVID-19 pandemic lockdown period had a negative effect on the BNP and NTproBNP market. This is due to stringent governmental controls and limits that resulted in fewer cardiac disease diagnostic tests being performed. In addition, the low level of knowledge and the high price of diagnostic tests during the COVID period further hindered market growth. COVID-19, however, was also capable of causing venous and arterial thrombosis, arrhythmia, and cardiac damage. Thus, optimizing cardiac illness detection and therapy was crucial, which eventually led to a rise in the usage of point-of-care BNP & NT-proBNP testing.

Market Growth Factors

Rising prevalence of CAD, AMI, and CHF around the world

The Global Health Data Exchange database estimates that there is currently 64.34 million congestive heart failure (CHF) cases worldwide. This amounts to USD 346.17 billion spent on healthcare and 9.91 million YLDs (years lost due to disability). HF is significantly influenced by age. Moreover, cardiovascular issues can significantly reduce a patient's functional capacity and raise their mortality risk. Therefore, to avoid repeated hospital stays, optimize patient outcomes, and boost the quality of life, it is crucial to correctly diagnose and treat the disease. As a result, the population's increased prevalence of cardiovascular illness presents an opportunity for leading market participants to invest in and commercialize the products and, in turn, accelerate the growth of the bnp and ntprobnp market.

Growing use of bnp and Ntprobnp assays in chronic kidney disease

The heart is affected by these changes and develops cardiomyopathy and congestive heart failure over time. Markers for this involvement include natriuretic peptides like BNP and NT-proBNP. Natriuretic peptide levels are higher in people with CKD, especially those receiving dialysis. It has been observed that a more accurate risk indicator for CKD is the variations in BNP levels over time. It is important to highlight that renal function and NT-pro-BNP levels are highly inversely correlated in renal failure. Therefore, the increasing use of bnp and ntprobnp assays to diagnose renal function accurately to treat CKD has resulted in market expansion.

Market Restraining Factors

Non-interchangeable nature of bnp and ntprobnp assays

No published investigation had evaluated the diagnostic concordance of BNP & NT-proBNP for ruling out and ruling in HF at the established cut-points, despite the broad recognition that both tests are fundamentally clinically comparable. Measuring BNP or NT-proBNP in patient samples has several well-known problems, such as variable antibody reactivity with the precursor proBNP and changes in half-lives, renal clearance, protein glycosylation, and biochemical variety in HF patients. Hence, it is obvious that BNP and NT-proBNP cannot be used interchangeably. This increases the expense of these test assays and presents factors that will slow down the market's growth.

Application Outlook

Based on application, the BNP and NT-proBNP market is categorized into myocardial infarction, congestive heart failure (CHF), acute coronary syndrome (ACS), and others. The congestive heart failure segment procured a considerable growth rate in the BNP and NT-proBNP market in 2021. Congestive heart failure, or CHF, is a gradual, chronic illness that impairs the ability of the heart muscle to contract. These metrics have been demonstrated to reduce costs in the emergency room setting and can be used to identify heart failure, particularly diastolic dysfunction. BNP testing' high negative predictive accuracy is especially useful for excluding heart failure.

Location of Testing Outlook

On the basis of location of testing, the BNP and NT-proBNP market is divided into point of care testing and laboratory testing. The point of care testing segment acquired the largest revenue share in the BNP and NT-proBNP market in 2021. Better resource utilization, increased patient convenience, growth in demand for cardiology biomarker testing, and improved clinical decision-making are all credited with this. It also results from improved heart failure diagnosis and treatment. Most point-of-care testing equipment includes kits, assays, analyzers, and devices focused on testing.

BNP and NT-proBNP Market Report Coverage

Report Attribute	Details
Market size value in 2021	USD 1 Billion
Market size forecast in 2028	USD 2.2 Billion
Base Year	2021
Historical Period	2018 to 2020
Forecast Period	2022 to 2028
Revenue Growth Rate	CAGR of 11.4% from 2022 to 2028
Number of Pages	170
Number of Table	260
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered	Location of Testing, Application, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Rising prevalence of CAD, AMI, and CHF around the world Growing use of bnp and Ntprobnp assays in chronic kidney disease
Restraints	Non-interchangeable nature of bnp and ntprobnp assays

Regional Outlook

Based on region, the BNP and NT-proBNP market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed the maximum revenue share in the BNP and NT-proBNP market in 2021. This can be ascribed to the advanced healthcare system and the widespread use of BNP and NTproBNP as diagnostic and prognostic disease tools. In addition, the need for testing products is driven by the growing elderly population's need for biomarker testing to diagnose diseases like acute myocardial infarction. Another factor boosting the expansion of this market is the concentration of important companies in the region.

Free Valuable Insights: Global BNP and NT-proBNP Market size to reach USD 2.2 Billion by 2028

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Siemens AG, Danaher Corporation, Gentian Diagnostics ASA, PerkinElmer, Inc., BioMérieux S.A., Quidel Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd. (Roche Holding Ltd.), and Scripps Laboratories.

Scope of the Study

Market Segments Covered in the Report:

By Location of Testing

• Point of Care Testing
• Laboratory Testing

By Application

• Myocardial Infarction
• Acute Coronary Syndrome (ACS)
• Congestive Heart Failure (CHF)
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Abbott Laboratories
• Siemens AG
• Danaher Corporation
• Gentian Diagnostics ASA
• PerkinElmer, Inc.
• BioMérieux S.A.
• Quidel Corporation
• Bio-Rad Laboratories, Inc.
• F.Hoffmann-La Roche Ltd. (Roche Holding Ltd.)
• Scripps Laboratories

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global BNP and NT-proBNP Market, by Location of Testing
1.4.2 Global BNP and NT-proBNP Market, by Application
1.4.3 Global BNP and NT-proBNP Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global BNP and NT-proBNP Market by Location of Testing
3.1 Global Point of Care Testing Market by Region
3.2 Global Laboratory Testing Market by Region

Chapter 4. Global BNP and NT-proBNP Market by Application
4.1 Global Myocardial Infarction Market by Region
4.2 Global Acute Coronary Syndrome (ACS) Market by Region
4.3 Global Congestive Heart Failure (CHF) Market by Region
4.4 Global Others Market by Region

Chapter 5. Global BNP and NT-proBNP Market by Region
5.1 North America BNP and NT-proBNP Market
5.1.1 North America BNP and NT-proBNP Market by Location of Testing
5.1.1.1 North America Point of Care Testing Market by Country
5.1.1.2 North America Laboratory Testing Market by Country
5.1.2 North America BNP and NT-proBNP Market by Application
5.1.2.1 North America Myocardial Infarction Market by Country
5.1.2.2 North America Acute Coronary Syndrome (ACS) Market by Country
5.1.2.3 North America Congestive Heart Failure (CHF) Market by Country
5.1.2.4 North America Others Market by Country
5.1.3 North America BNP and NT-proBNP Market by Country
5.1.3.1 US BNP and NT-proBNP Market
5.1.3.1.1 US BNP and NT-proBNP Market by Location of Testing
5.1.3.1.2 US BNP and NT-proBNP Market by Application
5.1.3.2 Canada BNP and NT-proBNP Market
5.1.3.2.1 Canada BNP and NT-proBNP Market by Location of Testing
5.1.3.2.2 Canada BNP and NT-proBNP Market by Application
5.1.3.3 Mexico BNP and NT-proBNP Market
5.1.3.3.1 Mexico BNP and NT-proBNP Market by Location of Testing
5.1.3.3.2 Mexico BNP and NT-proBNP Market by Application
5.1.3.4 Rest of North America BNP and NT-proBNP Market
5.1.3.4.1 Rest of North America BNP and NT-proBNP Market by Location of Testing
5.1.3.4.2 Rest of North America BNP and NT-proBNP Market by Application
5.2 Europe BNP and NT-proBNP Market
5.2.1 Europe BNP and NT-proBNP Market by Location of Testing
5.2.1.1 Europe Point of Care Testing Market by Country
5.2.1.2 Europe Laboratory Testing Market by Country
5.2.2 Europe BNP and NT-proBNP Market by Application
5.2.2.1 Europe Myocardial Infarction Market by Country
5.2.2.2 Europe Acute Coronary Syndrome (ACS) Market by Country
5.2.2.3 Europe Congestive Heart Failure (CHF) Market by Country
5.2.2.4 Europe Others Market by Country
5.2.3 Europe BNP and NT-proBNP Market by Country
5.2.3.1 Germany BNP and NT-proBNP Market
5.2.3.1.1 Germany BNP and NT-proBNP Market by Location of Testing
5.2.3.1.2 Germany BNP and NT-proBNP Market by Application
5.2.3.2 UK BNP and NT-proBNP Market
5.2.3.2.1 UK BNP and NT-proBNP Market by Location of Testing
5.2.3.2.2 UK BNP and NT-proBNP Market by Application
5.2.3.3 France BNP and NT-proBNP Market
5.2.3.3.1 France BNP and NT-proBNP Market by Location of Testing
5.2.3.3.2 France BNP and NT-proBNP Market by Application
5.2.3.4 Russia BNP and NT-proBNP Market
5.2.3.4.1 Russia BNP and NT-proBNP Market by Location of Testing
5.2.3.4.2 Russia BNP and NT-proBNP Market by Application
5.2.3.5 Spain BNP and NT-proBNP Market
5.2.3.5.1 Spain BNP and NT-proBNP Market by Location of Testing
5.2.3.5.2 Spain BNP and NT-proBNP Market by Application
5.2.3.6 Italy BNP and NT-proBNP Market
5.2.3.6.1 Italy BNP and NT-proBNP Market by Location of Testing
5.2.3.6.2 Italy BNP and NT-proBNP Market by Application
5.2.3.7 Rest of Europe BNP and NT-proBNP Market
5.2.3.7.1 Rest of Europe BNP and NT-proBNP Market by Location of Testing
5.2.3.7.2 Rest of Europe BNP and NT-proBNP Market by Application
5.3 Asia Pacific BNP and NT-proBNP Market
5.3.1 Asia Pacific BNP and NT-proBNP Market by Location of Testing
5.3.1.1 Asia Pacific Point of Care Testing Market by Country
5.3.1.2 Asia Pacific Laboratory Testing Market by Country
5.3.2 Asia Pacific BNP and NT-proBNP Market by Application
5.3.2.1 Asia Pacific Myocardial Infarction Market by Country
5.3.2.2 Asia Pacific Acute Coronary Syndrome (ACS) Market by Country
5.3.2.3 Asia Pacific Congestive Heart Failure (CHF) Market by Country
5.3.2.4 Asia Pacific Others Market by Country
5.3.3 Asia Pacific BNP and NT-proBNP Market by Country
5.3.3.1 China BNP and NT-proBNP Market
5.3.3.1.1 China BNP and NT-proBNP Market by Location of Testing
5.3.3.1.2 China BNP and NT-proBNP Market by Application
5.3.3.2 Japan BNP and NT-proBNP Market
5.3.3.2.1 Japan BNP and NT-proBNP Market by Location of Testing
5.3.3.2.2 Japan BNP and NT-proBNP Market by Application
5.3.3.3 India BNP and NT-proBNP Market
5.3.3.3.1 India BNP and NT-proBNP Market by Location of Testing
5.3.3.3.2 India BNP and NT-proBNP Market by Application
5.3.3.4 South Korea BNP and NT-proBNP Market
5.3.3.4.1 South Korea BNP and NT-proBNP Market by Location of Testing
5.3.3.4.2 South Korea BNP and NT-proBNP Market by Application
5.3.3.5 Singapore BNP and NT-proBNP Market
5.3.3.5.1 Singapore BNP and NT-proBNP Market by Location of Testing
5.3.3.5.2 Singapore BNP and NT-proBNP Market by Application
5.3.3.6 Malaysia BNP and NT-proBNP Market
5.3.3.6.1 Malaysia BNP and NT-proBNP Market by Location of Testing
5.3.3.6.2 Malaysia BNP and NT-proBNP Market by Application
5.3.3.7 Rest of Asia Pacific BNP and NT-proBNP Market
5.3.3.7.1 Rest of Asia Pacific BNP and NT-proBNP Market by Location of Testing
5.3.3.7.2 Rest of Asia Pacific BNP and NT-proBNP Market by Application
5.4 LAMEA BNP and NT-proBNP Market
5.4.1 LAMEA BNP and NT-proBNP Market by Location of Testing
5.4.1.1 LAMEA Point of Care Testing Market by Country
5.4.1.2 LAMEA Laboratory Testing Market by Country
5.4.2 LAMEA BNP and NT-proBNP Market by Application
5.4.2.1 LAMEA Myocardial Infarction Market by Country
5.4.2.2 LAMEA Acute Coronary Syndrome (ACS) Market by Country
5.4.2.3 LAMEA Congestive Heart Failure (CHF) Market by Country
5.4.2.4 LAMEA Others Market by Country
5.4.3 LAMEA BNP and NT-proBNP Market by Country
5.4.3.1 Brazil BNP and NT-proBNP Market
5.4.3.1.1 Brazil BNP and NT-proBNP Market by Location of Testing
5.4.3.1.2 Brazil BNP and NT-proBNP Market by Application
5.4.3.2 Argentina BNP and NT-proBNP Market
5.4.3.2.1 Argentina BNP and NT-proBNP Market by Location of Testing
5.4.3.2.2 Argentina BNP and NT-proBNP Market by Application
5.4.3.3 UAE BNP and NT-proBNP Market
5.4.3.3.1 UAE BNP and NT-proBNP Market by Location of Testing
5.4.3.3.2 UAE BNP and NT-proBNP Market by Application
5.4.3.4 Saudi Arabia BNP and NT-proBNP Market
5.4.3.4.1 Saudi Arabia BNP and NT-proBNP Market by Location of Testing
5.4.3.4.2 Saudi Arabia BNP and NT-proBNP Market by Application
5.4.3.5 South Africa BNP and NT-proBNP Market
5.4.3.5.1 South Africa BNP and NT-proBNP Market by Location of Testing
5.4.3.5.2 South Africa BNP and NT-proBNP Market by Application
5.4.3.6 Nigeria BNP and NT-proBNP Market
5.4.3.6.1 Nigeria BNP and NT-proBNP Market by Location of Testing
5.4.3.6.2 Nigeria BNP and NT-proBNP Market by Application
5.4.3.7 Rest of LAMEA BNP and NT-proBNP Market
5.4.3.7.1 Rest of LAMEA BNP and NT-proBNP Market by Location of Testing
5.4.3.7.2 Rest of LAMEA BNP and NT-proBNP Market by Application

Chapter 6. Company Profiles
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 SWOT Analysis
6.2 Siemens AG
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 SWOT Analysis
6.3 Danaher Corporation
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Gentian Diagnostics ASA
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expenses
6.5 PerkinElmer, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 BioMérieux S.A.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Quidel Corporation
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.8 Bio-Rad laboratories, Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expenses
6.9 F. Hoffmann-La Roche Ltd. (Roche Holding Ltd.)
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
6.10. Scripps Laboratories
6.10.1 Company Overview

TABLE 1 Global BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 2 Global BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 3 Global BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 4 Global BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 5 Global Point of Care Testing Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Point of Care Testing Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Laboratory Testing Market by Region, 2018 - 2021, USD Million
TABLE 8 Global Laboratory Testing Market by Region, 2022 - 2028, USD Million
TABLE 9 Global BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 10 Global BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 11 Global Myocardial Infarction Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Myocardial Infarction Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Acute Coronary Syndrome (ACS) Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Acute Coronary Syndrome (ACS) Market by Region, 2022 - 2028, USD Million
TABLE 15 Global Congestive Heart Failure (CHF) Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Congestive Heart Failure (CHF) Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 19 Global BNP and NT-proBNP Market by Region, 2018 - 2021, USD Million
TABLE 20 Global BNP and NT-proBNP Market by Region, 2022 - 2028, USD Million
TABLE 21 North America BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 22 North America BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 23 North America BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 24 North America BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 25 North America Point of Care Testing Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Point of Care Testing Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Laboratory Testing Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Laboratory Testing Market by Country, 2022 - 2028, USD Million
TABLE 29 North America BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 30 North America BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 31 North America Myocardial Infarction Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Myocardial Infarction Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Acute Coronary Syndrome (ACS) Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Acute Coronary Syndrome (ACS) Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Congestive Heart Failure (CHF) Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Congestive Heart Failure (CHF) Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 39 North America BNP and NT-proBNP Market by Country, 2018 - 2021, USD Million
TABLE 40 North America BNP and NT-proBNP Market by Country, 2022 - 2028, USD Million
TABLE 41 US BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 42 US BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 43 US BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 44 US BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 45 US BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 46 US BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 47 Canada BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 48 Canada BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 49 Canada BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 50 Canada BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 51 Canada BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 52 Canada BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 53 Mexico BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 54 Mexico BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 55 Mexico BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 56 Mexico BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 57 Mexico BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 58 Mexico BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 59 Rest of North America BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 60 Rest of North America BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 61 Rest of North America BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 62 Rest of North America BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 63 Rest of North America BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 64 Rest of North America BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 65 Europe BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 66 Europe BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 67 Europe BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 68 Europe BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 69 Europe Point of Care Testing Market by Country, 2018 - 2021, USD Million
TABLE 70 Europe Point of Care Testing Market by Country, 2022 - 2028, USD Million
TABLE 71 Europe Laboratory Testing Market by Country, 2018 - 2021, USD Million
TABLE 72 Europe Laboratory Testing Market by Country, 2022 - 2028, USD Million
TABLE 73 Europe BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 74 Europe BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 75 Europe Myocardial Infarction Market by Country, 2018 - 2021, USD Million
TABLE 76 Europe Myocardial Infarction Market by Country, 2022 - 2028, USD Million
TABLE 77 Europe Acute Coronary Syndrome (ACS) Market by Country, 2018 - 2021, USD Million
TABLE 78 Europe Acute Coronary Syndrome (ACS) Market by Country, 2022 - 2028, USD Million
TABLE 79 Europe Congestive Heart Failure (CHF) Market by Country, 2018 - 2021, USD Million
TABLE 80 Europe Congestive Heart Failure (CHF) Market by Country, 2022 - 2028, USD Million
TABLE 81 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 82 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 83 Europe BNP and NT-proBNP Market by Country, 2018 - 2021, USD Million
TABLE 84 Europe BNP and NT-proBNP Market by Country, 2022 - 2028, USD Million
TABLE 85 Germany BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 86 Germany BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 87 Germany BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 88 Germany BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 89 Germany BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 90 Germany BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 91 UK BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 92 UK BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 93 UK BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 94 UK BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 95 UK BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 96 UK BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 97 France BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 98 France BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 99 France BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 100 France BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 101 France BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 102 France BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 103 Russia BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 104 Russia BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 105 Russia BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 106 Russia BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 107 Russia BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 108 Russia BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 109 Spain BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 110 Spain BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 111 Spain BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 112 Spain BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 113 Spain BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 114 Spain BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 115 Italy BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 116 Italy BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 117 Italy BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 118 Italy BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 119 Italy BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 120 Italy BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 121 Rest of Europe BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 122 Rest of Europe BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 123 Rest of Europe BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 124 Rest of Europe BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 125 Rest of Europe BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 126 Rest of Europe BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 127 Asia Pacific BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 128 Asia Pacific BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 129 Asia Pacific BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 130 Asia Pacific BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 131 Asia Pacific Point of Care Testing Market by Country, 2018 - 2021, USD Million
TABLE 132 Asia Pacific Point of Care Testing Market by Country, 2022 - 2028, USD Million
TABLE 133 Asia Pacific Laboratory Testing Market by Country, 2018 - 2021, USD Million
TABLE 134 Asia Pacific Laboratory Testing Market by Country, 2022 - 2028, USD Million
TABLE 135 Asia Pacific BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 136 Asia Pacific BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 137 Asia Pacific Myocardial Infarction Market by Country, 2018 - 2021, USD Million
TABLE 138 Asia Pacific Myocardial Infarction Market by Country, 2022 - 2028, USD Million
TABLE 139 Asia Pacific Acute Coronary Syndrome (ACS) Market by Country, 2018 - 2021, USD Million
TABLE 140 Asia Pacific Acute Coronary Syndrome (ACS) Market by Country, 2022 - 2028, USD Million
TABLE 141 Asia Pacific Congestive Heart Failure (CHF) Market by Country, 2018 - 2021, USD Million
TABLE 142 Asia Pacific Congestive Heart Failure (CHF) Market by Country, 2022 - 2028, USD Million
TABLE 143 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 144 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 145 Asia Pacific BNP and NT-proBNP Market by Country, 2018 - 2021, USD Million
TABLE 146 Asia Pacific BNP and NT-proBNP Market by Country, 2022 - 2028, USD Million
TABLE 147 China BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 148 China BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 149 China BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 150 China BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 151 China BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 152 China BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 153 Japan BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 154 Japan BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 155 Japan BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 156 Japan BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 157 Japan BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 158 Japan BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 159 India BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 160 India BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 161 India BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 162 India BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 163 India BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 164 India BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 165 South Korea BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 166 South Korea BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 167 South Korea BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 168 South Korea BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 169 South Korea BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 170 South Korea BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 171 Singapore BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 172 Singapore BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 173 Singapore BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 174 Singapore BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 175 Singapore BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 176 Singapore BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 177 Malaysia BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 178 Malaysia BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 179 Malaysia BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 180 Malaysia BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 181 Malaysia BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 182 Malaysia BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 183 Rest of Asia Pacific BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 184 Rest of Asia Pacific BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 185 Rest of Asia Pacific BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 186 Rest of Asia Pacific BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 187 Rest of Asia Pacific BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 188 Rest of Asia Pacific BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 189 LAMEA BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 190 LAMEA BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 191 LAMEA BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 192 LAMEA BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 193 LAMEA Point of Care Testing Market by Country, 2018 - 2021, USD Million
TABLE 194 LAMEA Point of Care Testing Market by Country, 2022 - 2028, USD Million
TABLE 195 LAMEA Laboratory Testing Market by Country, 2018 - 2021, USD Million
TABLE 196 LAMEA Laboratory Testing Market by Country, 2022 - 2028, USD Million
TABLE 197 LAMEA BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 198 LAMEA BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 199 LAMEA Myocardial Infarction Market by Country, 2018 - 2021, USD Million
TABLE 200 LAMEA Myocardial Infarction Market by Country, 2022 - 2028, USD Million
TABLE 201 LAMEA Acute Coronary Syndrome (ACS) Market by Country, 2018 - 2021, USD Million
TABLE 202 LAMEA Acute Coronary Syndrome (ACS) Market by Country, 2022 - 2028, USD Million
TABLE 203 LAMEA Congestive Heart Failure (CHF) Market by Country, 2018 - 2021, USD Million
TABLE 204 LAMEA Congestive Heart Failure (CHF) Market by Country, 2022 - 2028, USD Million
TABLE 205 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 206 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 207 LAMEA BNP and NT-proBNP Market by Country, 2018 - 2021, USD Million
TABLE 208 LAMEA BNP and NT-proBNP Market by Country, 2022 - 2028, USD Million
TABLE 209 Brazil BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 210 Brazil BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 211 Brazil BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 212 Brazil BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 213 Brazil BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 214 Brazil BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 215 Argentina BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 216 Argentina BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 217 Argentina BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 218 Argentina BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 219 Argentina BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 220 Argentina BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 221 UAE BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 222 UAE BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 223 UAE BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 224 UAE BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 225 UAE BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 226 UAE BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 227 Saudi Arabia BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 228 Saudi Arabia BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 229 Saudi Arabia BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 230 Saudi Arabia BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 231 Saudi Arabia BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 232 Saudi Arabia BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 233 South Africa BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 234 South Africa BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 235 South Africa BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 236 South Africa BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 237 South Africa BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 238 South Africa BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 239 Nigeria BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 240 Nigeria BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 241 Nigeria BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 242 Nigeria BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 243 Nigeria BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 244 Nigeria BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 245 Rest of LAMEA BNP and NT-proBNP Market, 2018 - 2021, USD Million
TABLE 246 Rest of LAMEA BNP and NT-proBNP Market, 2022 - 2028, USD Million
TABLE 247 Rest of LAMEA BNP and NT-proBNP Market by Location of Testing, 2018 - 2021, USD Million
TABLE 248 Rest of LAMEA BNP and NT-proBNP Market by Location of Testing, 2022 - 2028, USD Million
TABLE 249 Rest of LAMEA BNP and NT-proBNP Market by Application, 2018 - 2021, USD Million
TABLE 250 Rest of LAMEA BNP and NT-proBNP Market by Application, 2022 - 2028, USD Million
TABLE 251 Key Information – Abbott Laboratories
TABLE 252 Key Information – Siemens AG
TABLE 253 Key Information – Danaher Corporation
TABLE 254 Key Information – Gentian Diagnostics ASA
TABLE 255 key Information – PerkinElmer, Inc.
TABLE 256 Key information – BioMérieux S.A.
TABLE 257 key information – Quidel Corporation
TABLE 258 Key Information – Bio-Rad Laboratories, Inc.
TABLE 259 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 260 Key Information – Scripps Laboratories

List of Figures
FIG 1 Methodology for the research
FIG 2 Global BNP and NT-proBNP Market Share by Location of Testing, 2021
FIG 3 Global BNP and NT-proBNP Market Share by Location of Testing, 2028
FIG 4 Global BNP and NT-proBNP Market by Location of Testing, 2018 - 2028, USD Million
FIG 5 Global BNP and NT-proBNP Market Share by Application, 2021
FIG 6 Global BNP and NT-proBNP Market Share by Application, 2028
FIG 7 Global BNP and NT-proBNP Market by Application, 2018 - 2028, USD Million
FIG 8 Global BNP and NT-proBNP Market Share by Region, 2021
FIG 9 Global BNP and NT-proBNP Market Share by Region, 2028
FIG 10 Global BNP and NT-proBNP Market by Region, 2018 - 2028, USD Million
FIG 11 Swot analysis: Abbott laboratories
FIG 12 Swot analysis: Siemens AG